-
Duration-Dependent Hypoxia and Urothelial Inflammation
2026-09-26
Hudson and colleagues used enzyme-induced hypoxia in rat urothelial cells to distinguish an early hypoxic response from inflammation associated with longer oxygen deprivation. Their results support a duration-dependent, ROS-associated TXNIP/NLRP3 pathway, while highlighting the need for additional experiments to establish the pathway’s individual steps and relevance in vivo.
-
Lipid Peroxidation (MDA) Assay Kit in Ferroptosis
2026-09-26
Connect ferroptosis biology to a measurable lipid-oxidation endpoint with a workflow for cell and tissue studies of sunitinib response. The kit supports absorbance or fluorescence readout, with a reported 1–200 μM linear range and sensitivity down to 1 μM.
-
Sitagliptin Phosphate Monohydrate and Gut Stretch
2026-09-25
Sitagliptin phosphate monohydrate is a DPP-4 inhibitor for studying incretin biology, but gut-stretch research reveals why glucose and feeding outcomes cannot be assigned to hormones alone. Learn how to design experiments that separate these signals and interpret their interaction.
-
Chloroquine and Itch: A Sensory-Neuroscience View
2026-09-25
Chloroquine is more than a lysosomal and autophagy research tool: it is also a recognized activator of itch-related sensory neurons. This article connects that pharmacology to new findings on chronic dermatitis, showing how to design experiments that distinguish direct sensory activation from disease-driven sensitization.
-
Fangchinoline Restores TFEB Lysosomal Defense Against H1N1
2026-09-24
Cheng and colleagues identify fangchinoline as a lysosome-accumulating compound that activates TFEB, restores lysosomal gene expression, and inhibits H1N1 infection, with time-resolved assays pointing to viral entry as the principal affected stage. The findings support further study of lysosomal modulation as a host-directed antiviral strategy, while leaving important questions about dose, safety, and broader applicability for future work.
-
Reproducible iPSC-to-RGC Differentiation
2026-09-24
Chavali and colleagues developed a chemically defined approach that combines dual SMAD and canonical Wnt inhibition to direct induced pluripotent stem cells toward retinal ganglion cells. The method produced cultures with greater than 80% RGC purity and enabled further enrichment to nearly 95% Thy-1-positive cells, offering a more reproducible starting point for retinal disease modeling and cell-based research.
-
Cytochalasin D for Actin-Dependent Uptake Assays
2026-09-23
Use Cytochalasin D to separate true nanoparticle internalization from actin-dependent surface association in human corneal epithelial models. This workflow pairs controlled cytoskeletal perturbation with pathway-focused uptake measurements, morphology checks, and viability controls.
-
Cyclophosphamide Workflows for Cancer Research
2026-09-22
Build more reproducible Cyclophosphamide assays for apoptosis, immune modulation, and translational oncology. This guide combines a validated 9L gliosarcoma workflow with PK/PD-inspired experimental design from a neutropenic infection study, while clearly separating established evidence from practical recommendations.
-
RITA (NSC 652287) Assay Workflow for Cancer Biology
2026-09-22
RITA (NSC 652287) provides a focused way to interrogate MDM2–p53 signaling, selective cytotoxicity, and DNA cross-linking in cancer models. This workflow pairs dose–response data with time-resolved cell-death measurements so growth inhibition is not mistaken for apoptosis.
-
L. plantarum P101 Activates AMPK in Alcoholic Fatty Liver
2026-09-21
A 2025 study found that Lactiplantibacillus plantarum P101 reduced alcohol-induced hepatic lipid accumulation in mice and linked this effect to AMPK activation. Pharmacological inhibition, gut microbiota profiling, and serum metabolomics together support a gut–liver mechanism while identifying microbial and metabolite correlates for further study.
-
Berbamine hydrochloride: Ferroptosis Workflow Guide
2026-09-21
Use Berbamine hydrochloride as a research probe for connecting STAT3, calcium homeostasis, and NF-κB activity with ferroptosis-related phenotypes in leukemia and hepatocellular carcinoma models. This workflow emphasizes dose anchoring, orthogonal readouts, and direct testing of the METTL16-SENP3-LTF axis rather than treating cytotoxicity alone as proof of mechanism.
-
Mestranol and Reversible Lysosomal Stress in Microglia
2026-09-20
A 2026 Aquatic Toxicology study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia, separating impaired cargo digestion from loss of phagocytic uptake or widespread cell death. Its live-imaging, functional, transcriptomic, and TFEC-rescue framework provides a useful model for investigating environmental estrogen–associated neuroimmunotoxicity.
-
ZIF8 Nanotheranostics for Ultrasound-Guided TNBC Therapy
2026-09-19
Li et al. developed a folic acid–PEG-functionalized ZIF8 nanoplatform that delivers ciprofloxacin while combining ultrasound-triggered sonodynamic therapy, chemotherapy, immune activation, and imaging. The study provides a useful design framework for pH-responsive, actively targeted nanotheranostics, while also highlighting the experimental controls needed to distinguish carrier effects, ultrasound effects, and drug-specific activity.
-
DMH1: Reframing BMP Control in Organoid Translation
2026-09-19
DMH1 offers translational researchers a selective way to interrogate ALK2-driven BMP signaling, linking receptor-proximal mechanism with organoid engineering and non-small cell lung cancer research. This thought-leadership perspective distinguishes what is established from what remains to be tested when DMH-1 is moved from tumor models into tunable epithelial organoid systems.
-
SpCas9 mRNA: Workflow and Troubleshooting
2026-09-18
Build a transient CRISPR workflow around optimized SpCas9 mRNA for controllable editing in cells, embryos, and delivery studies. Learn how modified RNA chemistry, guide design, LNP selection, and time-matched assays can improve interpretation from DNA double-strand break induction through genotype confirmation.